ZLAB Q1 2022 Earnings — Zai Lab Limited Revenue & Financial Results | Market Cap Arena

ZLABZai Lab Limited

$2B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$47M+132.4% YoY

Gross Profit

-$23M-48.7% margin

Operating Income

-$80M-170.7% margin

Net Income

-$82M-176.3% margin

EPS (Diluted)

$-8.60

QoQ Revenue Growth

+5.8%

Cash Flow

Operating Cash Flow

-$87M

Free Cash Flow

-$97M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$193M

Stockholders' Equity

$1.3B

Cash & Equivalents

$847M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$47M	$20M	+132.4%
Gross Profit	-$23M	-$191M	+88.1%
Operating Income	-$80M	-$227M	+64.9%
Net Income	-$82M	-$233M	+64.6%

Revenue Segments

Zejula

$30M64%

Optune

$13M28%

Qinlock

$3M6%

Nuzyra

$742,0002%